Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17667193 | 0.90 | ALDH1A1 (0.49) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| O-Xylene SCHEMBL27476227 | 0.90 | ALDH1A1 (0.63) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| SCHEMBL28099793 | 0.90 | ALDH1A1 (0.51) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| SCHEMBL728307 | 0.85 | ALDH1A1 (0.50) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| Toluene SCHEMBL9571021 | 0.82 | TDP1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| SCHEMBL6577504 | 0.82 | ALDH1A1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| Toluene SCHEMBL289971 | 0.82 | TDP1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| Toluene SCHEMBL9388822 | 0.82 | TDP1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| SCHEMBL3848081 | 0.82 | ALDH1A1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 | |
| Toluene SCHEMBL28119644 | 0.82 | TDP1 (0.55) | ALDH1A1GLATDP1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160096964-A1 | FLAKY GRAPHITE CONTAINING BORON AND PRODUCTION METHOD THEREFOR | SHOWA DENKO K.K. (JP) | 2016-04-07 | — | — | US | disclosed |
| EP-2998271-A1 | FLAKY GRAPHITE CONTAINING BORON AND PRODUCTION METHOD THEREFOR | Showa Denko K.K. (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20090280331-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090274916-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD (JP) | 2009-11-05 | — | — | US | disclosed |
| EP-2050756-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-04-22 | — | — | EP | disclosed |
| EP-2048147-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-7064157-B2 | Epoxy resin modified with a side chain having a reactive phosphorus-containing compound, e.g., 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide | CHANG CHUN PLASTICS CO., LTD. (TW) | 2006-06-20 | — | — | US | disclosed |
| US-6818307-B2 | COMPRISES POLYPHOSPHAZENE COMPOUND AS HARDENING PROMOTER; FOR PRODUCTION OF DIELECTRICS/PRINTED CIRCUIT BOARDS; PREPREGS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-11-16 | — | — | US | disclosed |
| US-20040019134-A1 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS CO., LTD. | 2004-01-29 | — | — | US | disclosed |
| US-6660786-B2 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS, CO., LTD. (TW) | 2003-12-09 | — | — | US | disclosed |
| US-20020128397-A1 | Phenolic resins modified with phosphorus oxychloride (POCl3) of given formula; flame retardant properties and high heat resistance so as not to require additional flame retardants; use as electronic packaging material | CHANG CHUN PLASTICS CO. LTD. (TW) | 2002-09-12 | — | — | US | disclosed |
| US-20020082322-A1 | Flame retarded epoxy resin composition | CHANG CHUN PLASTICS, CO., LTD. (TW) | 2002-06-27 | — | — | US | disclosed |
| US-20020032279-A1 | Flame retardant resin and flame retardant composition containing the same | CHANG CHUN PLASTICS CO., LTD. | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274916-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | P2RX5, P2RX4, KDM5A | ALDH1A1 2049/4885GLA 1876/4885TDP1 906/4885 |
| US-20090280331-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | P2RX5, KDM5A, P2RX4 | ALDH1A1 1946/4885GLA 1868/4885TDP1 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.